Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 2000, p. 2230-2230, Vol. 44, No. 8
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
LETTERS TO THE EDITOR
Are SHV
-Lactamases Universal in Klebsiella
pneumoniae?
 |
LETTER |
The status of SHV-1 or related
-lactamases as "typical" of
Klebsiella pneumoniae prompted debate at the 39th
Interscience Conference of Antimicrobial Agents and Chemotherapy. To
test whether SHV-type enzymes are ubiquitous in this species, as
previously asserted by one of us, (2) we screened 20 isolates identified as K. pneumoniae with API 20E tests
(BioMerieux, Lyons, France). The isolates were obtained in
1997-1998 from intensive care units across Europe (1) and
were chosen as broadly susceptible to
-lactam antibiotics
including aztreonam (MIC
0.25 µg/ml), ceftazidime (MIC
0.25 µg/ml), ceftazidime plus clavulanic acid, 4 µg/ml (MIC
0.25 µg/ml), cefuroxime (MIC
4 µg/ml),
ceftriaxone (MIC
0.12 µg/ml), piperacillin (MIC
8 µg/ml), piperacillin plus tazobactam, 4 µg/ml (MIC
4 µg/ml), cefoxitin (MIC
8 µg/ml), cefotetan (MIC
0.12 µg/ml), and meropenem (MIC
0.12 µg/ml). The MIC ratio
of ceftazidime to ceftazidime plus clavulanic acid equalled unity,
except for one isolate where it was 2, indicating the absence of
extended-spectrum
-lactamases. The isolates were from 16 hospitals
in eight European countries.
Screening for blaSHV genes was by PCR, initially
using primers 5'-TCA GCG AAA AAC ACC TTG-3' and 5'-TCC CGC AGA TAA ATC
ACC A-3' (5) to amplify a 475-bp fragment. These primers
correspond to positions 509 to 526 and 962 to 980, respectively, in the
blaSHV-1 sequence (GenBank accession number
AF124984). Amplification of a DNA fragment of the expected size was
achieved with 18 of the 20 isolates. The two isolates that failed to
give amplification products were reidentified with biochemical tests
(4). One was deduced to be K. oxytoca on the
basis of pectate degradation, utilization of
m-hydroxybenzoate, and the ability to grow at 10°C but was
indole negative and so was not recognized as K. oxytoca by
the API 20E system. The second isolate was confirmed as K. pneumoniae. This isolate was retested for
blaSHV-related DNA using primers
5'-ATGCGTTATATTCGCCTGTG-3' and
5'-GTTAGCGTTGCCAGTGCTCG-3', corresponding to positions 199 to 210 and 1041 to 1060, respectively, of
blaSHV-1. These primers amplified an 865-bp
fragment, corresponding to the entire coding region of
blaSHV.
Phenotypic expression of blaSHV was examined by
isoelectric focusing, performed as described by Livermore and Williams
(3).
-Lactamases that cofocused with SHV-1 enzyme (pI
7.6) were detected in 16 of the 19 confirmed K. pneumoniae
strains. No
-lactamase band was detected in extracts of the three
remaining isolates, indicating that expression was absent or below the
detection limit of the nitrocefin overlay. These three organisms gave
inhibition zones 3 to 7 mm larger to discs containing amoxicillin plus
clavulanate at 20 + 10 µg than to those containing ampicillin at 25 µg, suggesting that some slight
-lactamase activity was present
despite the electrofocusing result. Surprisingly, and despite its lack
of piperacillin resistance, one SHV-1-positive isolate also had a
-lactamase that cofocused with TEM-1 enzyme.
We conclude that blaSHV-related genes were
present in all 19 confirmed K. pneumoniae isolates and were
expressed in at least 16 of these strains, which were from diverse
European sources and were selected as highly susceptible to
-lactams. These data support the view that SHV-related enzymes
approach ubiquity in K. pneumoniae, at least in Europe.
 |
ACKNOWLEDGMENTS |
We are grateful to colleagues in the Laboratory of Hospital
Infection for the identification of the two isolates by biochemical tests.
We are grateful to AstraZeneca for financial support.
 |
FOOTNOTES |
*
Phone: 44-020-8200-400
Fax: 44-020-8358-3292
E-mail: Dlivermore{at}phls.nhs.uk
 |
REFERENCES |
| 1.
|
Babini, G. S., and D. M. Livermore.
2000.
Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-98.
J. Antimicrob. Chemother.
45:183-189[Abstract/Free Full Text].
|
| 2.
|
Livermore, D. M.
1995.
-Lactamases in laboratory and clinical resistance.
Clin. Microbiol. Rev.
8:557-584[Abstract].
|
| 3.
|
Livermore, D. M., and J. D. Williams.
1996.
-Lactams: mode of action and mechanisms of antibacterial resistance, p. 502-577.
In
V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., Baltimore, Md.
|
| 4.
|
Podschun, R., and U. Ullmann.
1998.
Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.
Clin. Microbiol. Rev.
11:589-603[Abstract/Free Full Text].
|
| 5.
|
Yuan, M.,
H. Aucken,
L. M. C. Hall,
T. L. Pitt, and D. M. Livermore.
1998.
Epidemiological typing of klebsiellae with extended-spectrum -lactamases from European intensive care units.
J. Antimicrob. Chemother.
41:527-539[Abstract/Free Full Text].
|
| | | | |
Gioia S. Babini
David M. Livermore*
Antibiotic Resistance Monitoring & Reference Laboratory Central Public Health Laboratory London, United Kingdom, NW9 5HT
|
Antimicrobial Agents and Chemotherapy, August 2000, p. 2230-2230, Vol. 44, No. 8
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Andersson, P., Harris, T., Tong, S. Y. C., Giffard, P. M.
(2009). Analysis of blaSHV Codon 238 and 240 Allele Mixtures Using Sybr Green High-Resolution Melting Analysis. Antimicrob. Agents Chemother.
53: 2679-2683
[Abstract]
[Full Text]
-
Haanpera, M., Forssten, S. D., Huovinen, P., Jalava, J.
(2008). Typing of SHV Extended-Spectrum {beta}-Lactamases by Pyrosequencing in Klebsiella pneumoniae Strains with Chromosomal SHV {beta}-Lactamase. Antimicrob. Agents Chemother.
52: 2632-2635
[Abstract]
[Full Text]
-
Hammond, D. S., Harris, T., Bell, J., Turnidge, J., Giffard, P. M.
(2008). Selection of SHV Extended-Spectrum-{beta}-Lactamase-Dependent Cefotaxime and Ceftazidime Resistance in Klebsiella pneumoniae Requires a Plasmid-Borne blaSHV Gene. Antimicrob. Agents Chemother.
52: 441-445
[Abstract]
[Full Text]
-
Hocquet, D., Berthelot, P., Roussel-Delvallez, M., Favre, R., Jeannot, K., Bajolet, O., Marty, N., Grattard, F., Mariani-Kurkdjian, P., Bingen, E., Husson, M.-O., Couetdic, G., Plesiat, P.
(2007). Pseudomonas aeruginosa May Accumulate Drug Resistance Mechanisms without Losing Its Ability To Cause Bloodstream Infections. Antimicrob. Agents Chemother.
51: 3531-3536
[Abstract]
[Full Text]
-
Alves, M. S., Dias, R. C. d. S., de Castro, A. C. D., Riley, L. W., Moreira, B. M.
(2006). Identification of Clinical Isolates of Indole-Positive and Indole-Negative Klebsiella spp.. J. Clin. Microbiol.
44: 3640-3646
[Abstract]
[Full Text]
-
Paterson, D. L., Bonomo, R. A.
(2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev.
18: 657-686
[Abstract]
[Full Text]
-
Siebor, E., Pechinot, A., Duez, J.-M., Neuwirth, C.
(2005). One New LEN Enzyme and Two New OKP Enzymes in Klebsiella pneumoniae Clinical Isolates and Proposed Nomenclature for Chromosomal {beta}-Lactamases of This Species. Antimicrob. Agents Chemother.
49: 3097-3098
[Full Text]
-
Jacoby, G. A., Munoz-Price, L. S.
(2005). The New {beta}-Lactamases. NEJM
352: 380-391
[Full Text]
-
Ford, P. J., Avison, M. B.
(2004). Evolutionary mapping of the SHV {beta}-lactamase and evidence for two separate IS26-dependent blaSHV mobilization events from the Klebsiella pneumoniae chromosome. J Antimicrob Chemother
54: 69-75
[Abstract]
[Full Text]
-
Melano, R., Corso, A., Petroni, A., Centron, D., Orman, B., Pereyra, A., Moreno, N., Galas, M.
(2003). Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum {beta}-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina. J Antimicrob Chemother
52: 36-42
[Abstract]
[Full Text]
-
Hocquet, D., Bertrand, X., Kohler, T., Talon, D., Plesiat, P.
(2003). Genetic and Phenotypic Variations of a Resistant Pseudomonas aeruginosa Epidemic Clone. Antimicrob. Agents Chemother.
47: 1887-1894
[Abstract]
[Full Text]
-
Sabate, M., Miro, E., Navarro, F., Verges, C., Aliaga, R., Mirelis, B., Prats, G.
(2002). {beta}-Lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain). J Antimicrob Chemother
49: 989-997
[Abstract]
[Full Text]
-
Chaves, J., Ladona, M. G., Segura, C., Coira, A., Reig, R., Ampurdanes, C.
(2001). SHV-1 {beta}-Lactamase Is Mainly a Chromosomally Encoded Species-Specific Enzyme in Klebsiella pneumoniae. Antimicrob. Agents Chemother.
45: 2856-2861
[Abstract]
[Full Text]
-
Chang, F.-Y., Siu, L. K., Fung, C.-P., Huang, M.-H., Ho, M.
(2001). Diversity of SHV and TEM {beta}-Lactamases in Klebsiella pneumoniae: Gene Evolution in Northern Taiwan and Two Novel {beta}-Lactamases, SHV-25 and SHV-26. Antimicrob. Agents Chemother.
45: 2407-2413
[Abstract]
[Full Text]